Imeik Technology Development Co.,Ltd. (SHE:300896)

Market Cap	30.03B -42.6%
Revenue (ttm)	2.42B -15.9%
Net Income	1.15B -38.9%
EPS	3.80 -38.9%
Shares Out	301.43M
PE Ratio	26.22
Forward PE	21.62
Dividend	1.60 (1.57%)
Ex-Dividend Date	Apr 29, 2026

Volume	3,188,162
Open	104.00
Previous Close	102.20
Day's Range	98.53 - 104.00
52-Week Range	98.53 - 202.88
Beta	0.78
Analysts	Buy
Price Target	147.32 (+47.9%)
Earnings Date	Aug 19, 2026

About SHE:300896

Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; a...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,458
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300896

Financial Performance

In 2025, SHE:300896's revenue was 2.45 billion, a decrease of -18.94% compared to the previous year's 3.03 billion. Earnings were 1.29 billion, a decrease of -34.05%.